Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Equillium, Inc. Director's Dealing 2018

Oct 16, 2018

34270_dirs_2018-10-16_94ee22e0-f249-4da5-9091-4143b31d7f8a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Equillium, Inc. (EQ)
CIK: 0001746466
Period of Report: 2018-10-16

Reporting Person: Biocon SA (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-10-16 Common Stock A 228060 $0.00 Acquired 2316134 Direct

Footnotes

F1: This shares were acquired pursuant to certain anti-dilution rights for no additional consideration.